Brown Brothers Harriman & Co’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-629
Closed -$49K 1249
2022
Q3
$49K Buy
+629
New +$50.3K ﹤0.01% 740
2019
Q4
Sell
-9
Closed 1102
2019
Q3
$0 Hold
9
﹤0.01% 1185
2019
Q2
$0 Buy
+9
New +$291 ﹤0.01% 1096
2018
Q4
Sell
-60
Closed -$2K 935
2018
Q3
$2K Hold
60
﹤0.01% 781
2018
Q2
$2K Hold
60
﹤0.01% 770
2018
Q1
$2K Sell
60
-35
-37% -$1.28K ﹤0.01% 740
2017
Q4
$3K Buy
+95
New +$3.29K ﹤0.01% 927
2017
Q2
Sell
-734
Closed -$32K 749
2017
Q1
$32K Sell
734
-74
-9% -$3K ﹤0.01% 532
2016
Q4
$27K Buy
808
+734
+992% +$28.5K ﹤0.01% 581
2016
Q3
$4K Hold
74
﹤0.01% 702
2016
Q2
$4K Buy
+74
New +$4.33K ﹤0.01% 728

Other funds holding ACHC

Brown Brothers Harriman & Co's ACHC Position: Q4 2022 in Review

Brown Brothers Harriman & Co sold out of Acadia Healthcare (ACHC) in Q4 2022, closing a stake of 629 shares — an estimated $49K sold.

Brown Brothers Harriman & Co first reported a position in ACHC in Q2 2016 and held it in 11 quarters. The position peaked at $49K in Q3 2022. 346 funds tracked by Wall St. Rank hold ACHC as of Q4 2022.

  • Brown Brothers Harriman & Co reported no remaining Acadia Healthcare position as of Q4 2022 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 629 Acadia Healthcare shares in Q4 2022, an estimated $49K.
  • Brown Brothers Harriman & Co first reported a position in Acadia Healthcare in Q2 2016 and held it in 11 quarters.
  • Brown Brothers Harriman & Co's Acadia Healthcare position peaked at $49K in Q3 2022.
  • 346 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2022.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2022, filed 9 Feb 2023.